Omrix Biopharmaceuticals, Inc. (OMRI)

S&amp;P 500: 1,262.90
Change: 0.11%

A commercial-stage biopharmaceutical company that develops and markets innovative biological products.

Recs

Avatar KenN513 (93.13) Submitted: 7/16/07 11:31 AM : Start Price: $33.33 OMRI Score: 31.00

PEG is 3+. Other indicators are good, but the market has valued them.

Featured Broker Partners